Zist Arvand Pharmed Company (DARVAND) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DARVAND
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1405/06/31 |
|---|---|
| P/E TTM | 10.11 |
| P/S TTM | 3.75 |
| P/B | 5.91 |
| Gross margin TTM | 72.6% |
| Net margin TTM | 37.1% |
| ROA TTM | 21.4% |
| ROE TTM | 58.4% |
| Collection period TTM | 155 days |
| Inventory period TTM | 423 days |
| PEGY TTM | 3.01 |